Cover Image
Read Now

Drug-resistant tuberculosis a review of the guidelines

The purpose of this report is to review and critically appraise the evidence-based guidelines regarding DR-TB. This report is part of series of evidence reviews on TB guidelines and can serve as a guidance document to identify which guidelines include recommendations for DR-TB. This report does not...

Full description

Bibliographic Details
Main Authors: Brett, Kendra, Dulong, Camille (Author), Severn, Melissa (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health March 9, 2020, 2020
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Evidence-based Medicine
Guidelines As Topic
Tuberculosis, Multidrug-resistant
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01687nam a2200301 u 4500
001 EB001999838
003 EBX01000000000000001162739
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Brett, Kendra 
245 0 0 |a Drug-resistant tuberculosis  |h Elektronische Ressource  |b a review of the guidelines  |c Kendra Brett, Camille Dulong, Melissa Severn 
250 |a Version 1.0 
260 |a Ottawa (ON)  |b Canadian Agency for Drugs and Technologies in Health  |c March 9, 2020, 2020 
300 |a 1 PDF file (39 pages) 
505 0 |a Includes bibliographical references 
653 |a Evidence-Based Medicine 
653 |a Guidelines as Topic 
653 |a Tuberculosis, Multidrug-Resistant 
700 1 |a Dulong, Camille  |e [author] 
700 1 |a Severn, Melissa  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health  |b Rapid Response Service 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report: summary with critical appraisal 
856 4 0 |u http://www.ncbi.nlm.nih.gov/books/NBK562941  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The purpose of this report is to review and critically appraise the evidence-based guidelines regarding DR-TB. This report is part of series of evidence reviews on TB guidelines and can serve as a guidance document to identify which guidelines include recommendations for DR-TB. This report does not cover LTBI and drug susceptible TB, which can be found in separate reports. This report focuses on strategies for the prevention, identification, and treatment of DR-TB. 

Similar Items